Could stem cell eye drops soothe dry eyes?

NCT ID NCT07623382

Recruiting now Symptom relief Sponsor: The First Affiliated Hospital of Xiamen University Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This early study tests eye drops made from stem cell particles in 20 adults with dry eye disease. Participants use the drops four times daily for four weeks. Researchers track safety and symptom changes like eye staining and tear film stability.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: human umbilical cord mesenchymal stem cell-derived small extracellular vesicle eye drops
What this could lead to: If successful, this could point toward a new way to ease dry eye symptoms using natural cell products.
What could go wrong: This is a very early, small trial with only 20 people. It mainly checks safety, and the drops may not work better than existing treatments.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DRY EYE DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

dry eye syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DRY EYE DISEASE UMBILICAL CORD MESENCHYMAL STEM CELL-DERIVED SMALL EXTRACELLULAR VESICLES

Contacts and locations

Locations

The First Affiliated Hospital of Xiamen University
RECRUITING

Xiamen, China, 361000, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.